Category Specific RSS

ovarian cancer

IPO Watch: Cleo Diagnostics to go public with ovarian cancer test kits to address 51% survival rate

As diseases continue to adapt, the realm of medical diagnostics must intelligently progress to adeptly combat these changes. Timely interventions…

2 years ago